These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 9414714)

  • 21. Delayed graft function incidence as predictive variable of survival of kidney grafts retrieved from elderly donors.
    Carmellini M; Vistoli F; Boggi U; Bellini R; Mosca F
    Transplant Proc; 2000 Feb; 32(1):128-30. PubMed ID: 10700995
    [No Abstract]   [Full Text] [Related]  

  • 22. The prognostic utility of deceased donor implantation biopsy in determining function and graft survival after kidney transplantation.
    Cockfield SM; Moore RB; Todd G; Solez K; Gourishankar S
    Transplantation; 2010 Mar; 89(5):559-66. PubMed ID: 20110855
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contribution of late acute rejection to long-term renal allograft survival in patients with chronic allograft nephropathy.
    Sezer S; Ozdemir FN; Akcay A; Colak T; Kut A; Haberal M
    Transplant Proc; 2003 Nov; 35(7):2637-8. PubMed ID: 14612049
    [No Abstract]   [Full Text] [Related]  

  • 24. Long-term effect of cyclooxygenase inhibition with acetylsalicylic acid in cadaveric renal transplants.
    Abendroth D; Schelzig H; Mickley V; Storck M
    Transplant Proc; 1997 Nov; 29(7):3004-5. PubMed ID: 9365645
    [No Abstract]   [Full Text] [Related]  

  • 25. Kidney transplant using pediatric donors--effect on long-term graft and patient survival.
    Arrazola L; Sozen H; Humar A; Papalois V; Uknis M; Matas AJ
    Transplant Proc; 2000 Nov; 32(7):1839. PubMed ID: 11119962
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of antithymocyte globulin induction treatment on renal transplant outcome.
    Sanchez-Fructuoso AI; Naranjo P; Torrente J; Fernández-Pérez C; Avilés B; Prats D; Barrientos A
    Transplant Proc; 1998 Aug; 30(5):1790-2. PubMed ID: 9723284
    [No Abstract]   [Full Text] [Related]  

  • 27. Kidney transplantation from older ( > or = 55 years) donors: a risk factor for graft survival.
    Mizutani K; Katoh N; Yamada S; Ono Y; Takeuchi N; Matsuura O; Ohshima S
    Transplant Proc; 1996 Jun; 28(3):1589-90. PubMed ID: 8658797
    [No Abstract]   [Full Text] [Related]  

  • 28. Primary tacrolimus immunosuppression in kidney recipients considered "higher immunologic risk".
    Braun F; Lorf T; Schütz E; Canelo R; Hanack U; Döpkens K; Sattler B; Grupp C; Ringe B
    Transplant Proc; 2000 Nov; 32(7):2535. PubMed ID: 11120281
    [No Abstract]   [Full Text] [Related]  

  • 29. Long-term comparison of tacrolimus and cyclosporine-based immunosuppression in kidney recipients with grafts from non-heart-beating cadaver donor.
    Kinukawa T; Ohshima S; Ono Y; Fujita T; Hattori R; Tanaka K
    Transplant Proc; 1998 Jun; 30(4):1227-9. PubMed ID: 9636498
    [No Abstract]   [Full Text] [Related]  

  • 30. The impact of donor and recipient age on the outcome of kidney transplantation.
    Kwon OJ; Lee HG; Kwak JY
    Transplant Proc; 2004 Sep; 36(7):2043-5. PubMed ID: 15518739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical outcome of cadaveric renal transplantation with non-heart-beating donors: special reference to serious complications.
    Hiraga S; Kitamura M; Kakuta T; Takebayashi Y; Fukuuchi F; Kitajima N; Hida M
    Transplant Proc; 1997 Dec; 29(8):3561-4. PubMed ID: 9414837
    [No Abstract]   [Full Text] [Related]  

  • 32. Single center experience of 1500 kidney transplants.
    Park K; Kim YS; Kim SI; Kim MS; Moon JI
    Transplant Proc; 1998 Nov; 30(7):3088-9. PubMed ID: 9838362
    [No Abstract]   [Full Text] [Related]  

  • 33. "Very urgent" kidney transplantation: results from one center.
    Costa S; Ventura A; Costa T; Martins L; Henriques A; Sarmento A
    Transplant Proc; 2003 May; 35(3):1066. PubMed ID: 12947858
    [No Abstract]   [Full Text] [Related]  

  • 34. Kidney transplantation utilizing donors from both age extremes.
    Genyk Y; Burrows L; Knight RJ
    Transplant Proc; 1997 Dec; 29(8):3655-6. PubMed ID: 9414877
    [No Abstract]   [Full Text] [Related]  

  • 35. Experience in one center of combined kidney and liver transplantation in 22 patients: incidence of graft rejection and long-term graft outcome.
    Larue JR; Hiesse C; Samuel D; Blanchet P; Bensadoun H; Benoit G; Castaing D; Adam R; Charpentier B; Bismuth H
    Transplant Proc; 1997; 29(1-2):243-4. PubMed ID: 9122981
    [No Abstract]   [Full Text] [Related]  

  • 36. The impact of gender and age matching for long-term graft survival in living donor renal transplantation.
    Kwon OJ; Kwak JY; Kang CM
    Transplant Proc; 2005 Mar; 37(2):726-8. PubMed ID: 15848514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deceased donor management and demographic factors related to kidney allograft rejection and graft survival.
    Slakey LM; Slakey CM; Slakey DP
    Transplant Proc; 2010 Jun; 42(5):1513-8. PubMed ID: 20620465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of delayed graft function on graft survival in living donor kidney transplantation.
    Kwon OJ; Ha MK; Kwak JY; Lee HW
    Transplant Proc; 2003 Feb; 35(1):92-3. PubMed ID: 12591321
    [No Abstract]   [Full Text] [Related]  

  • 39. Steroid-free immunosuppression in renal transplantation: a long-term follow-up of 100 consecutive patients.
    Birkeland SA
    Transplantation; 2001 Apr; 71(8):1089-90. PubMed ID: 11374407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors on graft survival of living donor kidney transplantation.
    Park YH; Min SK; Lee JN; Lee HH; Jung WK; Lee JS; Lee JH; Lee YD
    Transplant Proc; 2004 Sep; 36(7):2023-5. PubMed ID: 15518732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.